线粒体Ca2+在癌症生长和代谢中的作用
Jillian S Weissenrieder1,2, J Kevin Foskett1,2
1Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Journal of cellular physiology
|September 23, 2025
概括
癌细胞代谢的改变,特别是线粒体 (Ca2+) 调节,呈现出新的治疗点. 了解这些联系可以通过调节营养依赖或途径,导致新的抗癌策略.
科学领域:
- 在瘤学瘤学.
- 细胞的新陈代谢
- 线粒体生物学 线粒体生物学
背景情况:
- 尽管有针对性的治疗方法取得了进展,但癌症仍然是导致死亡的主要原因.
- 奥托·沃伯格 (Otto Warburg) 在20世纪20年代首次注意到癌细胞中的代谢失调.
- 线粒体 (Ca2+) 稳态越来越多地与瘤代谢有关.
研究的目的:
- 审查关于线粒体Ca2+恒温,癌症代谢及其相互联系的文献.
- 讨论针对线粒体Ca2+作为抗癌治疗策略的潜力.
主要方法:
- 科学文章和研究论文的文献评论.
- 关于癌细胞代谢和线粒体Ca2+信号传递的发现的综合.
- 基于当前研究的治疗影响的讨论.
主要成果:
- 不调节的细胞代谢是癌症的标志.
- 改变的线粒体Ca2+稳态显著影响癌细胞代谢.
- 准代谢脆弱性为新的癌症治疗提供了潜力.
结论:
- 线粒体Ca2+调制是新型抗癌疗法的一个有希望的途径.
- 需要进一步研究线粒体Ca2+与癌症代谢之间的相互作用.
- 利用代谢依赖可以改善患者的治疗结果.
相关概念视频
Electron Transport Chain: Complex I and II
18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitochondria
19.6K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.6K
Mitochondrial Membranes
16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K


